Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
FDA Launches Real‑Time Clinical Trial Monitoring to Accelerate Drug Reviews
The U.S. Food and Drug Administration announced the completion of its first real‑time clinical trial monitoring tests, partnering with AstraZeneca and Amgen to stream safety and efficacy data live to regulators. The initiative uses AI and electronic health‑record integration to shrink the months‑long gaps that traditionally delay drug approvals.
Humana Q1 Profit Falls to $1.18B, EPS Drops 5% Amid Health‑insurance Margin Pressure
Humana Inc. posted first‑quarter profit of $1.18 billion, down from $1.24 billion a year earlier, while earnings per share slipped to $9.83 from $10.30. Revenue rose 23.5% to $39.64 billion, yet the company trimmed its full‑year EPS outlook to $9.00, underscoring pressure on...
Medix Infusion Names Carmine DeNardo CEO to Accelerate National Expansion
Medix Infusion announced Carmine DeNardo as its new President and CEO, leveraging his experience growing ReCept Pharmacy from $32 million to over $600 million. The move signals a push to broaden ambulatory infusion services across the U.S. and deepen payer‑manufacturer partnerships.
Dr. Reddy’s Announces Health Canada Approval of Generic Semaglutide Injection
Dr. Reddy’s Laboratories received a Notice of Compliance from Health Canada, becoming the first firm to secure market authorization for a generic semaglutide injection in Canada. The approval covers both 2 mg and 4 mg pen formulations, and the company is preparing...
Actian Unveils VectorAI DB, a Portable, Compliance‑Focused Vector Database
Actian introduced VectorAI DB, its first vector database designed for on‑premises, edge and self‑hosted deployments. The product ships with a free community edition for up to 5,000 vectors and paid plans starting at $417 per month, aiming at regulated sectors...
Art and Recovery Cards Unite Colorado for Healing
Honored to join the Behavioral Health Administration’s 150/250 celebration at the Denver Public Library. Art connects and heals—proud to see the Recovery Cards Project support Coloradans on their path to recovery. A healthy Colorado means access to care for all.
GSK‑Ionis Antisense Drug Bepirovirsen Gets FDA Priority Review, Breakthrough Designation
GSK and its partner Ionis Pharmaceuticals announced that the FDA has placed bepirovirsen, an antisense oligonucleotide for chronic hepatitis B, on the priority‑review track and granted it breakthrough therapy designation. The move follows Phase 3 B‑Well data showing statistically significant functional‑cure...
Subtle Changes in Everyday Tasks Can Signal Alzheimer’s Risk Years Before Memory Loss
New research shows that persistent difficulties in everyday activities—such as cooking, shopping, or driving—can signal Alzheimer’s disease risk years before memory loss becomes apparent. Longitudinal studies found these functional impairments are linked to higher incidence of Alzheimer’s and to disease‑specific...
Gene Editing Swaps Whole Genes, Fixes 1,000 Mutations
A new genome editing technique enables efficient replacement of entire genes, allowing correction of up to 1,000 mutations simultaneously by inserting large DNA segments without causing toxic double-strand breaks. genetherapy
New Genome Editing Method Could Swap Entire Genes and Correct 1000 Mutations at Once
Scientists have unveiled a new genome‑editing platform called prime assembly that can insert DNA segments up to 11,000 base pairs, enabling the replacement of entire genes rather than single‑point edits. The method uses overlapping flaps to attach donor DNA without...
Cartesian Therapeutics Inc (RNAC) Q1 2026 Earnings Call Transcript
Wave Life Sciences reported a Q1 net loss of $46.9 million, with cash reserves of $243.1 million expected to fund operations into 2027. The DMD candidate WVE‑N531 delivered a statistically significant 3.8‑second improvement in time‑to‑rise and 7.8% average dystrophin expression,...
Syndax Pharmaceuticals Inc (SNDX) Q1 2026 Earnings Call Transcript
Syndax Pharmaceuticals reported $172 million total revenue for 2025, driven by $124.8 million from its menin inhibitor RevuForge and $151.6 million from the chronic‑GVHD therapy Nictimvo. RevuForge posted 38% quarter‑over‑quarter revenue growth and reached roughly 50% penetration of the KMT2A AML population, while...
Causal Evidence of Task-Switching Costs in Organ Transplantation
A new empirical study provides causal evidence that task‑switching interruptions add measurable time and risk to organ transplantation procedures. By linking real‑world operating‑room data with cognitive‑psychology models, the researchers show each intra‑operative switch adds roughly 12 minutes of cold‑ischemia time,...
Novocure Ltd (NVCR) Q1 2026 Earnings Call Transcript
NovoCure reported a record $655 million in net revenue for 2025, an 8% year‑over‑year increase driven by strong international patient growth. The company secured FDA approval for Optune Pax, its TTFields device targeting locally advanced pancreatic cancer, and began launch preparations in...
Alnylam Pharmaceuticals Inc (ALNY) Q1 2026 Earnings Call Transcript
Alnylam reported a strong Q1 2021 performance, with total product sales reaching $135.8 million, an 89% year‑over‑year increase. ONPATTRO generated $102 million in revenue, growing 13% quarter‑over‑quarter, while newly launched OXLUMO contributed $9 million and GIVLAARI $24.7 million. The company announced positive Phase 3 data...
Commentary: Clinical Knowledge Gaps Hinder Fight Against Smoking in Central Asia and Caucasus
Public health officials in Central Asia and the Caucasus are battling entrenched smoking rates, but a new Healthy Initiatives survey reveals that doctors lack essential cessation training. In Kazakhstan, more than four‑fifths of physicians have never received formal counseling education,...
Baxter International Inc (BAX) Q1 2026 Earnings Call Transcript
Baxter International reported $3.0 billion in global sales for the quarter, an 8% reported increase and 3% operational growth, while adjusted earnings per share fell to $0.44, missing internal expectations. Margin pressure stemmed from an unfavorable product mix, higher supply costs...
Pro-Dex Inc (PDEX) Q3 2026 Earnings Call Transcript
Becton Dickinson reported Q3 fiscal 2025 revenue of $5.5 billion, up 8.5% year‑over‑year and 3% organically, while adjusted gross margin rose to 54.8% and adjusted EPS reached $3.68, beating expectations. The company announced a definitive agreement to divest its Biosciences and...
Ardelyx Inc (ARDX) Q1 2026 Earnings Call Transcript
Ardelyx reported total Q3 2025 revenue of $110.3 million, a 12% increase year‑over‑year, driven primarily by a 92% surge in IBSRELA sales to $78.2 million. XPHOZAH contributed $27.4 million, marking a 9% sequential rise, and the company raised its full‑year IBSRELA revenue guidance...
Amgen Inc (AMGN) Q1 2026 Earnings Call Transcript
Amgen reported first‑quarter 2026 sales of $5.6 billion, a 4% year‑over‑year increase, driven by six high‑growth products that contributed 70% of total revenue. Repatha, Evenity, Test Buyer, TEPEZZA and the rare‑disease portfolio posted double‑digit growth, while legacy brands Prolia and XGEVA...
Select Medical Holdings Corp (SEM) Q1 2026 Earnings Call Transcript
Select Medical reported Q4 2025 revenue growth of over 6% while adjusted EBITDA fell 10% to $104.7 million, driven by an unexpected $15 million health‑insurance expense and $6 million variable discounts in outpatient rehab. The Board is evaluating a nonbinding take‑private proposal...
Cigna Group (CI) Q1 2026 Earnings Call Transcript
Cigna reported full‑year adjusted revenue of $275 billion, an 11% increase, and adjusted earnings per share of $29.84, up 9% year over year. Specialty and care services drove a 14% revenue jump to $26.7 billion, while specialty script volume grew 13%. The...
Kymera Therapeutics Inc (KYMR) Q1 2026 Earnings Call Transcript
Kymera Therapeutics reported Q1 2026 revenue of $2.8 million, entirely from its Gilead collaboration, and ended the quarter with $978.7 million in cash, extending its runway into the second half of 2028. The company completed enrollment and dosing for the Phase Ib atopic...
Angiocrine Signaling Drives Liver Fibrosis: From Mechanism to Early Clinical Translation
Researchers led by Hu et al. discovered that ROCK2 activity in liver sinusoidal endothelial cells is a pivotal driver of liver fibrosis. Single‑cell transcriptomics and knockout models revealed that ROCK2‑mediated cytoskeletal remodeling releases angiocrine factors that activate hepatic stellate cells. Early...
Organon & Co (OGN) Q1 2026 Earnings Call Transcript
Organon reported flat 2025 revenue of $6.2 billion and adjusted EBITDA of $1.9 billion, both reflecting a 3% decline year‑over‑year. The company highlighted a $390 million net cash inflow from the Jada system divestiture, earmarked for debt reduction to bring net leverage below...
Medical Properties Trust Inc (MPT) Q1 2026 Earnings Call Transcript
Medical Properties Trust reported Q1 2024 results, highlighting $1.6 billion of liquidity transactions and a $900 million cash sale of 75% of its Utah hospital portfolio while retaining a 25% interest. The company reduced net debt by $1.6 billion, now holding about $900 million...
Labcorp Holdings Inc (LH) Q1 2026 Earnings Call Transcript
Labcorp reported full‑year 2025 enterprise revenue up more than 7% and adjusted EPS rising 13%, driven by strong Diagnostics and Central Laboratory performance. Fourth‑quarter revenue reached $3.5 billion, margins expanded 120 basis points, and free cash flow hit $1.2 billion despite a seasonal...
Merit Medical Systems Inc (MMSI) Q1 2026 Earnings Call Transcript
Merit Medical Systems reported Q1 2021 GAAP revenue of $249 million, a 2.2% year‑over‑year increase, driven mainly by a 4.9% rise in international sales and modest U.S. growth. On a constant‑currency basis the company posted 0.6% revenue growth, surpassing its prior...
Long-Lived Immune Cells Show Promise Against Cancer in World-First Trial
A world‑first clinical trial tested CAR‑T therapy enriched with stem‑cell memory T cells, a long‑lived immune subset. In a small cohort of 11 patients with refractory blood cancers, five achieved complete remission and one partial remission, outperforming historical outcomes of...
AC Immune SA (ACIU) Q1 2026 Earnings Call Transcript
Eli Lilly reported a 56% year‑over‑year revenue surge in Q1 2026, propelled by its incretin portfolio—Mounjaro and Zepbound generated $12.8 billion in global sales. The company secured FDA approval for Koundeo, the first oral GLP‑1 for obesity, and logged over 20,000...
Encompass Health Corp (EHC) Q1 2026 Earnings Call Transcript
Encompass Health reported a strong Q1 2019, with consolidated revenue up 7.5% to $1.124 billion and adjusted EBITDA rising 8.8% to $242.9 million, delivering $1.04 earnings per share. The company announced a definitive agreement to acquire Alacare Home Health and Hospice, adding 46...
Option Care Health Inc (OPCH) Q1 2026 Earnings Call Transcript
Option Care Health reported fiscal 2025 net revenue of $5.6 billion, a 13% increase driven by balanced growth in acute and chronic infusion therapies. Adjusted EBITDA rose 6% to $471 million, delivering an 8.3% margin, while adjusted diluted EPS climbed 9% to...
Vaccines May Reduce Alzheimer Risk and Slow Aging
I'm getting two vaccines next week: Tdap and shingles. The Tdap because Kate's family has a newborn and we're visiting. Shingles for the potential longevity benefits. Data we're looking at: 1. Lower Alzheimer risk with vaccination in 1.6 million people,...
AI Flags Low‑GC Flu Strains, Warning of Pandemic Risk
A new AI classifier analyzes influenza A virus genomes to identify strains with reduced GC content, signaling a higher risk of sustained mammalian transmission and supporting earlier detection of potential pandemic threats. publichealth
Hongkongers Now Face Fines, Jail Time if Caught Carrying Vapes in Public
Hong Kong will enforce a new public‑place ban on alternative smoking products starting 30 April 2026. Carrying more than five vape pods or 100 heat sticks in public can result in up to six months imprisonment and a HK$50,000 (≈US$6,400) fine, while...
Peer Review Immunity Leaves Vulnerable Doctors Unprotected
You can buy malpractice insurance against a patient who thinks you harmed them. There is no insurance product, anywhere, that covers a physician against a peer who decides you are in the way. Up to 10 percent of peer reviews...
4 Notable Health Tech Funding Announcements in April
In April, health‑tech firms attracted sizable capital, underscoring investor confidence in AI‑driven and patient‑focused solutions. Chapter raised $100 million in a Series E round, pushing its valuation to $3 billion as it tackles Medicare plan mismatches. AcuityMD secured $80 million in Series C funding to...
Licensure, Ethics, Not Coaching: Protect Black Mental Health
In this video, I break down a clip from the @thejoebuddenpod featuring @_drbryant and explain why her messaging about licensure, ethics, and mental health care is harmful, especially to the Black community she claims to serve. A doctorate tells you...
![She Was Learning to Keep Others Breathing While Losing Her Own Air [PODCAST]](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://kevinmd.com/wp-content/uploads/lyndsay_hoy_thumbnail.png)
She Was Learning to Keep Others Breathing While Losing Her Own Air [PODCAST]
Anesthesiologist Lyndsay Hoy, diagnosed with the rare estrogen‑sensitive lung disease LAM at 28, recounts the daunting lack of coordinated reproductive guidance for women with rare conditions. She highlights how patients become de‑facto case managers, juggling pulmonology, genetics, and reproductive specialists...
343. Summary: Can This Nutrient Help Alzheimer's? - Life Extension
In this episode, Dr. Mike and Dr. Crystal discuss a recent pilot study on creatine supplementation as a potential therapy for Alzheimer's disease, featuring insights from lead author Aaron Smith. They explain how creatine, known for its role in muscle...
Exercise Boosts Psychedelic Therapy’s Antidepressant Effects
The combination of exercise and psychedelics for the treatment of major depressive disorder "Through the lens of psychological and behaviour change, psychedelics appear to facilitate the adoption or maintenance of physical activity habits, increase psychological flexibility, and since exercise is associated...
![[Comment] Evidence Into Action: Advancing Liver Health Policy in the WHO European Region](https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/94b44132c7b95808f65a0514466db2d9.webp)
[Comment] Evidence Into Action: Advancing Liver Health Policy in the WHO European Region
The World Health Organization’s European office highlights the launch of the second EASL‑Lancet Commission on liver health, building on the 2021 report to drive policy action across the region. The commentary notes that liver diseases, including cirrhosis and liver cancer,...
Omega’s Gourmand Sees Nursing Home Sector Investments as ‘Long-Term, Secular Plays’ Amid CommuniCare Divestments
Omega Healthcare Investors (OHI) reaffirmed its bullish stance on skilled nursing facilities, labeling them long‑term, secular plays despite recent divestments of CommuniCare assets. The REIT deployed $326 million in Q1 2026, highlighted by a $109 million purchase of 13 Georgia facilities yielding...
Efficacy of Magnesium Sulfate as an Adjuvant to Local Anesthetic in Erector Spinae Plane Block for Postoperative Analgesia After Modified...
Adding 200 mg magnesium sulfate to levobupivacaine in an erector spinae plane block significantly improved postoperative pain control for women undergoing modified radical mastectomy. In a randomized trial of 60 patients, morphine consumption fell by 33% and the interval to the...
Unintended Oversights Corrected: The Real Numbers
The blog post revisits a previous analysis of VAERSAWARE.com’s reporting on child deaths with unknown ages, asserting that the true count of vaccine‑related fatalities is significantly higher than official figures. It corrects an earlier claim by emphasizing that VAERSAWARE offers...
Tiny Biotech’s Experience Raises Questions About FDA’s Rare Disease Policies
BioCentury’s website now publishes a detailed cookie policy that separates cookies into five categories: strictly necessary, functional, marketing, advertising, and analytics. Strictly necessary cookies are always active and essential for authentication and navigation, while functional cookies enable personalization of the...
Nearly Half of Women Surveyed Still Think Breast Cancer Screening Starts at 50
A recent Ohio State University‑led survey of over 1,000 women found that 44% still believe breast cancer screening should begin at age 50, despite the U.S. Preventive Services Task Force’s 2024 update recommending biennial mammograms starting at age 40 for...
Hospitals Must Serve Real Food or Lose Funding
This is one of the biggest MAHA wins to date and it deserves a moment of attention, because hospitals are finally being told to align their patient meals with actual dietary guidelines or risk losing Medicare and Medicaid funding. That...
FDA Proposes AI-Driven Real-Time Trials, Ending Phase Gaps
No more Phase 1, 2, or 3 in clinical trials? The FDA is proposing using AI to get trial data in real-time from EHRs and giving trial design feedback based on what it sees. No more batch processing could eliminate the wait...
Inside Elevance Health’s Push to Keep Humans at the Center of AI-Driven Care
Elevance Health, together with Deloitte and Google Cloud, is rolling out a human‑centered AI platform to streamline provider inquiries, claim research, and correspondence management. The solution leverages Google’s open‑source Agent Development Kit to synthesize unstructured data and present pre‑assembled context...